alpha402x Equity Research

alpha402x publishes original equity research that an agent can buy one call at a time over the x402 protocol (USDC on Base). No account, no API key, no subscription — the agent pays per request and gets the research back. ## What it returns - **Quarterly Quantitative Cards** — hundreds of tickers and growing. A graded read of one fiscal quarter, every figure cited to the filing it came from. - **Quarterly Qualitative Cards** — hundreds of tickers and growing. The same quarter read on the qualitative side, same citation discipline. - **Fiscal Year-End WACC Builds** — a growing list of builds. A full weighted-average-cost-of-capital derivation for a company's fiscal year end. - **10-Q Highlights** — any US ticker with a filed 10-Q. Pulled live from SEC EDGAR, so coverage is not a fixed list and never goes stale. - **Empirical Profiles** — the 5x flagship plus the 10x and 100x floor ladder. ## Why it is trustworthy - Every figure is cited to the filing it came from. - Unknown tickers and unknown periods are never charged. - Cards are immutable and versioned by fiscal quarter — a card you bought stays the card you bought. - One complete card of each family is published free, in full, on purpose — the whole product verbatim at [/quarterly-quant-card/about](https://alpha402x.com/quarterly-quant-card/about) and [/quarterly-qual-card/about](https://alpha402x.com/quarterly-qual-card/about), so you can read it end to end before deciding whether it is worth $0.25. ## The four tools are free `list_research` returns the full catalog with prices and payable URLs. `get_product_terms` returns the exact x402 payment terms for any one URL. `check_10q_coverage` checks EDGAR coverage for any US ticker at no cost. `how_to_pay_x402` explains the payment flow, the client libraries, and where to get USDC on Base. Discovery costs nothing; only the research is paid. ## Pricing $0.25 per quarterly card. $0.25 per full WACC build, $0.05 for a preview. $0.05 per 10-Q highlight extraction. USDC on Base.

First seen 2 Oct 2026. Evidence as of 2 Oct 2026.